Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jean-Paul Concordet is active.

Publication


Featured researches published by Jean-Paul Concordet.


Journal of Biological Chemistry | 1996

Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1

Gregg L. Semenza; Bing-Hua Jiang; Sandra W. Leung; Rosa Passantino; Jean-Paul Concordet; Pascal Maire; Agata Giallongo

Hypoxia-inducible factor 1 (HIF-1) is a basic helix-loop-helix transcription factor which is expressed when mammalian cells are subjected to hypoxia and which activates transcription of genes encoding erythropoietin, vascular endothelial growth factor, and other proteins that are important for maintaining oxygen homeostasis. Previous studies have provided indirect evidence that HIF-1 also regulates transcription of genes encoding glycolytic enzymes. In this paper we characterize hypoxia response elements in the promoters of the ALDA, ENO1, and Ldha genes. We demonstrate that HIF-1 plays an essential role in activating transcription via these elements and show that although absolutely necessary, the presence of a HIF-1 binding site alone is not sufficient to mediate transcriptional responses to hypoxia. Analysis of hypoxia response elements in the ENO1 and Ldha gene promoters revealed that each contains two functionally-essential HIF-1 sites arranged as direct and inverted repeats, respectively. Our data establish that functional hypoxia-response elements consist of a pair of contiguous transcription factor binding sites at least one of which contains the core sequence 5′-RCGTG-3′ and is recognized by HIF-1. These results provide further evidence that the coordinate transcriptional activation of genes encoding glycolytic enzymes which occurs in hypoxic cells is mediated by HIF-1.


Molecular and Cellular Biology | 2006

Multisite Protein Kinase A and Glycogen Synthase Kinase 3β Phosphorylation Leads to Gli3 Ubiquitination by SCFβTrCP

Denis Tempé; Mariana Casas; Sonia Karaz; Marie-Françoise Blanchet-Tournier; Jean-Paul Concordet

ABSTRACT Gli3 is a zinc finger transcription factor proteolytically processed into a truncated repressor lacking C-terminal activation domains. Gli3 processing is stimulated by protein kinase A (PKA) and inhibited by Hedgehog signaling, a major signaling pathway in vertebrate development and disease. We show here that multisite glycogen synthase kinase 3β (GSK3β) phosphorylation and ubiquitination by SCFβTrCP are required for Gli3 processing. We identified multiple βTrCP-binding sites related to the DSGX2-4S motif in Gli3, which are intertwined with PKA and GSK3β sites, and SCFβTrCP target lysines that are essential for processing. Our results support a simple model whereby PKA triggers a cascade of Gli3 phosphorylation by GSK3β and CK1 that leads to direct βTrCP binding and ubiquitination by SCFβTrCP. Binding of βTrCP to Gli3 N- and C-terminal domains lacking DSGX2-4S-related motifs was also observed, which could reflect indirect interaction via other components of Hedgehog signaling, such as the tumor suppressor Sufu. Gli3 therefore joins a small set of transcription factors whose processing is regulated by the ubiquitin-proteasome pathway. Our study sheds light on the role of PKA phosphorylation in Gli3 processing and will help to analyze how dose-dependent tuning of Gli3 processing is achieved by Hedgehog signaling.


Molecular and Cellular Biology | 2004

Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality

Ara Parlakian; David Tuil; Ghislaine Hamard; Geneviève Tavernier; Danièle Hentzen; Jean-Paul Concordet; Denise Paulin; Zhenlin Li; Dominique Daegelen

ABSTRACT Serum response factor (SRF) is at the confluence of multiple signaling pathways controlling the transcription of immediate-early response genes and muscle-specific genes. There are active SRF target sequences in more than 50 genes expressed in the three muscle lineages including normal and diseased hearts. However, the role of SRF in heart formation has not been addressed in vivo thus far due to the early requirement of SRF for mesoderm formation. We have generated a conditional mutant of SRF by using Cre-LoxP strategy that will be extremely useful to study the role of SRF in embryonic and postnatal cardiac functions, as well as in other tissues. This report shows that heart-specific deletion of SRF in the embryo by using a new βMHC-Cre transgenic mouse line results in lethal cardiac defects between embryonic day 10.5 (E10.5) and E13.5, as evidenced by abnormally thin myocardium, dilated cardiac chambers, poor trabeculation, and a disorganized interventricular septum. At E9.5, we found a marked reduction in the expression of essential regulators of heart development, including Nkx2.5, GATA4, myocardin, and the SRF target gene c-fos prior to overt maldevelopment. We conclude that SRF is crucial for cardiac differentiation and maturation, acting as a global regulator of multiple developmental genes.


Journal of Biological Chemistry | 1999

Inducible degradation of Ikappa Balpha by the proteasome requires interaction with the F-box protein h-beta TrCP

Mathias Kroll; Florence Margottin; Alain Kohl; Patricia Renard; Hervé Durand; Jean-Paul Concordet; Françoise Bachelerie; Fernando Arenzana-Seisdedos; Richard Benarous

Activation of NF-κB transcription factors requires phosphorylation and ubiquitin-proteasome-dependent degradation of IκB proteins. We provide evidence that a human F-box protein, h-βTrCP, a component of Skp1-Cullin-F-box protein (SCF) complexes, a new class of E3 ubiquitin ligases, is essential for inducible degradation of IκBα. βTrCP associates with Ser32–Ser36 phosphorylated, but not with unmodified IκBα or Ser32–Ser36phosphorylation-deficient mutants. Expression of a F-box-deleted βTrCP inhibits IκBα degradation, promotes accumulation of phosphorylated Ser32–Ser36 IκBα, and prevents NF-κB-dependent transcription. Our findings indicate that βTrCP is the adaptor protein required for IκBα recognition by the SCFβTrCP E3 complex that ubiquitinates IκBα and makes it a substrate for the proteasome.


Nucleic Acids Research | 2005

Stable transmission of targeted gene modification using single-stranded oligonucleotides with flanking LNAs

Charlotte Andrieu-Soler; Mariana Casas; Anne-Marie Faussat; Christelle Gandolphe; M. Doat; Denis Tempé; Carine Giovannangeli; Francine Behar-Cohen; Jean-Paul Concordet

Targeted mutagenesis directed by oligonucleotides (ONs) is a promising method for manipulating the genome in higher eukaryotes. In this study, we have compared gene editing by different ONs on two new target sequences, the eBFP and the rd1 mutant photoreceptor βPDE cDNAs, which were integrated as single copy transgenes at the same genomic site in 293T cells. Interestingly, antisense ONs were superior to sense ONs for one target only, showing that target sequence can by itself impart strand-bias in gene editing. The most efficient ONs were short 25 nt ONs with flanking locked nucleic acids (LNAs), a chemistry that had only been tested for targeted nucleotide mutagenesis in yeast, and 25 nt ONs with phosphorothioate linkages. We showed that LNA-modified ONs mediate dose-dependent target modification and analyzed the importance of LNA position and content. Importantly, when using ONs with flanking LNAs, targeted gene modification was stably transmitted during cell division, which allowed reliable cloning of modified cells, a feature essential for further applications in functional genomics and gene therapy. Finally, we showed that ONs with flanking LNAs aimed at correcting the rd1 stop mutation could promote survival of photoreceptors in retinas of rd1 mutant mice, suggesting that they are also active in vivo.


Proceedings of the National Academy of Sciences of the United States of America | 2008

Triplex-forming oligonucleotide–orthophenanthroline conjugates for efficient targeted genome modification

Fabio Cannata; Erika Brunet; Loïc Perrouault; Victoria Roig; Slimane Ait-Si-Ali; Ulysse Asseline; Jean-Paul Concordet; Carine Giovannangeli

The inefficiency of gene modification by homologous recombination can be overcome by the introduction of a double-strand break (DSB) in the target. Engineering the endonucleases needed, however, remains a challenging task that limits widespread application of nuclease-driven gene modification. We report here that conjugates of orthophenanthroline (OP), a DNA cleaving molecule, and triplex-forming oligonucleotides (TFOs), known to bind specific DNA sequences, are synthetic nucleases efficient at stimulating targeted genome modification. We show that in cultured cells, OP-TFO conjugates induce targeted DSBs. An OP-TFO with a unique target was highly efficient, and mutations at the target site were found in ≈10% of treated cells, including small deletions most likely introduced during DSB repair by nonhomologous end joining. Importantly, we found that when homologous donor DNA was cotransfected, targeted gene modification took place in >1.5% of treated cells. Because triplex-forming sequences are frequent in human and mouse genes, OP-TFO conjugates therefore constitute an important class of site-specific nucleases for targeted gene modification. Harnessing DNA-damaging molecules to predetermined genomic sites, as achieved here, should also provide inroads into mechanisms of DNA repair and cancer.


Proceedings of the National Academy of Sciences of the United States of America | 1998

Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site

François Spitz; Josiane Demignon; Arlette Porteu; Axel Kahn; Jean-Paul Concordet; Dominique Daegelen; Pascal Maire


Nucleic Acids Research | 1991

A ubiquitous enhancer shared by two promoters in the human aldolase A gene

Jean-Paul Concordet; Pascal Maire; Axel Kahn; Dominique Daegelen


Methods | 2014

Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.

Carine Giovannangeli; Jean-Paul Concordet


Transplantation | 2018

Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models

Séverine Ménoret; Laure-Hélène Ouisse; Laurent Tesson; Frédéric Delbos; Delphine Garnier; Séverine Rémy; Claire Usal; Jean-Paul Concordet; Carine Giovannangeli; Vanessa Chenouard; Lucas Brusselle; Emmanuel Merieau; Véronique Nerrière-Daguin; Franck Duteille; F. Bellier-Waast; Alexandre Fraichard; Tuan H. Nguyen; Ignacio Anegon

Collaboration


Dive into the Jean-Paul Concordet's collaboration.

Top Co-Authors

Avatar

Carine Giovannangeli

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Axel Kahn

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Slimane Ait-Si-Ali

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Victoria Roig

Centre national de la recherche scientifique

View shared research outputs
Researchain Logo
Decentralizing Knowledge